Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-17

Clinical Trial Update: A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes ongoing Phase 1 and Phase 2 studies evaluating BMS-986470 in healthy volunteers and participants with sickle cell disease; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BMS-986470

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Anemia, Sickle Cell, Healthy Volunteers | Phase 1, Phase 2 | Status: RECRUITING